Process for preparing granisetron hydrochloride orally disintegrating tablets

A technology of granisetron hydrochloride and orally disintegrating tablets, which is applied in the field of powder feeders for new tablet presses, can solve the problems of inability to realize industrial production, poor tablet compressibility, and difficulty in control, and achieve cool and delicate taste, tablet The effect of small weight difference and fast disintegration and dissolution

Active Publication Date: 2009-01-14
HONGYI SCI & TECH CO LTD NANCHANG
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0034] In China, the preparation technology of orally disintegrating tablets started relatively late. At present, most of the orally disintegrating tablets are prepared by direct compression method. The degree of crushing, disintegration, and dissolution are difficult to control, and the compressibility of the tablet is poor, so industrial production cannot be realized

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for preparing granisetron hydrochloride orally disintegrating tablets

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0045] Granisetron hydrochloride (in C 18 h 24 N 4 O meter) 1g

[0046] Mannitol 40g

[0047] Microcrystalline Cellulose 25g

[0048] Low-substituted hydroxypropyl cellulose 6g

[0049] Croscarmellose Sodium 3g

[0050] Cross-linked polyvinylpyrrolidone 3g

[0051] Aspartame 0.8g

[0052] Citric acid (as C 6 h 8 o 7 meter) 0.5g

[0053] Micronized silica gel 2g

[0054] Magnesium Stearate 3g

[0055]

[0056] Makes 1000 pieces

[0057] Granisetron hydrochloride and mannitol, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, croscarmellose sodium, cross-linked polyvinylpyrrolidone, aspartame, citrate, micronized silica gel, hard Magnesium fatty acid auxiliary materials were crushed separately, mixed and sieved according to the prescription weight ratio, and the final mixed fine powder was placed in a powder feeder for a new tablet press, and compressed to produce granisetron hydrochloride orall...

example 2

[0059] Granisetron hydrochloride (in C 18 h 24 N 4 O meter) 1g

[0060] Mannitol 60g

[0061] Microcrystalline Cellulose 15g

[0062] Low-substituted hydroxypropyl cellulose 10g

[0063] Croscarmellose Sodium 5g

[0064] Cross-linked polyvinylpyrrolidone 5g

[0065] Aspartame 1g

[0066] Citric acid (as C 6 h 8 o 7 Count) 1g

[0067] Micronized silica gel 1g

[0068] Magnesium Stearate 2g

[0069]

[0070] Makes 1000 pieces

[0071] Granisetron hydrochloride and mannitol, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, croscarmellose sodium, cross-linked polyvinylpyrrolidone, aspartame, citrate, micronized silica gel, hard Magnesium fatty acid auxiliary materials were crushed separately, mixed and sieved according to the prescription weight ratio, and the final mixed fine powder was placed in a powder feeder for a new tablet press, and compressed to produce granisetron hydrochloride orally disi...

example 3

[0073] Granisetron hydrochloride (in C 18 h 24 N 4 O meter) 1g

[0074] Mannitol 50g

[0075] Microcrystalline Cellulose 20g

[0076] Low-substituted hydroxypropyl cellulose 15g

[0077] Croscarmellose Sodium 5g

[0078] Cross-linked polyvinylpyrrolidone 5g

[0079] Aspartame 1g

[0080] Citric acid (as C 6 h 8 o 7 meter) 0.5g

[0081] Micronized silica gel 0.5g

[0082] Magnesium stearate 0.5g

[0083]

[0084] Makes 1000 pieces

[0085] Granisetron hydrochloride and mannitol, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, croscarmellose sodium, cross-linked polyvinylpyrrolidone, aspartame, citrate, micronized silica gel, hard Magnesium fatty acid auxiliary materials were crushed separately, mixed and sieved according to the prescription weight ratio, and the final mixed fine powder was placed in a powder feeder for a new tablet press, and compressed to produce granisetron hydrochloride orall...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a formula and a process of a granisetron hydrochloride orally disintegrating tablet with a direct powder tabletting method and a novel powder feed device for a tabletting machine. Compared with the conventional technology of direct powder tabletting, the granisetron hydrochloride orally disintegrating tablet manufactured with the invention has cool and fine mouth feel, small difference of tablet weight, favorable uniformity of content, fast disintegration and dissolution, high dissolution rate and dissolubility, strong rigidity and favorable compressibility.

Description

technical field [0001] The invention relates to a prescription and a process for producing granisetron hydrochloride orally disintegrating tablets by a direct powder compression method and a novel powder feeder for a tablet machine. Background technique [0002] Tumor has become the first enemy that threatens human life and health. According to a research report released by the International Cancer Research Center of the World Health Organization in May 2003, according to the current trend of cancer incidence, the incidence of cancer in the world in 2002 increased by 50% compared with the past, and the number of new cancer patients in the world will reach 1500 every year. million people. According to the research report of the center, the cancer with the highest incidence rate in the world is lung cancer, with 1.2 million new patients every year; breast cancer, with about 1 million new patients every year; followed by bowel cancer with 940,000 and 940,000 new patients. Sto...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/439A61P9/10A61J3/10
Inventor 刘智钱进穆正义陶琳廖新华刘春阳熊水根陈晓华周治洋段建华颜锋刘孝乐
Owner HONGYI SCI & TECH CO LTD NANCHANG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products